Related Experiment Video

Updated: Oct 12, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.5K

Pore-forming Peptides: A New Treatment Option for Cancer

Zohreh Jahanafrooz1, Ahad Mokhtarzadeh2

  • 1Department of Biology, Faculty of Sciences, University of Maragheh, Maragheh, Iran.

Current Medicinal Chemistry
|November 26, 2021
PubMed

Insights

Pore-forming peptides (PFPs) offer a novel approach to cancer treatment by creating lethal pores in tumor cells. These natural defense proteins can overcome cancer cell resistance, presenting a promising therapeutic strategy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer remains a significant global health challenge, with drug resistance hindering treatment efficacy.
  • Pore-forming peptides (PFPs), natural defense proteins, exhibit antimicrobial and antifungal properties.
  • PFPs show potential as novel tumoricidal agents by forming pores in cancer cell membranes.

Purpose of the Study:

  • To explore the anticancer mechanisms of pore-forming peptides (PFPs).
  • To review studies on PFPs from various sources for cancer treatment.
  • To discuss strategies for selective PFP action against cancer cells and future perspectives.

Main Methods:

  • Review of existing literature on pore-forming peptides and their anticancer applications.
  • Analysis of PFP mechanisms of action, including pore formation and cell lysis.
  • Examination of strategies to enhance PFP selectivity towards cancer cells.

Main Results:

  • PFPs induce physical damage to cancer cell membranes, leading to cell death.
  • Natural and synthetic PFPs demonstrate efficacy in overcoming cancer cell resistance.
  • Various approaches have been developed to target PFPs specifically to tumor cells.

Conclusions:

  • Pore-forming peptides represent a promising class of anticancer agents due to their unique mechanism of action.
  • The development of selective PFPs could overcome resistance and improve cancer therapy outcomes.
  • Further research into PFPs offers significant potential for advancing cancer treatment strategies.
Keywords:
Cancer therapycell deathcell penetrating peptidescombination therapypore-forming peptidestargeted delivery

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

7.9K
Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids10:23

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

1.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
558
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
725
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K